The advent of novel nonsteroidal mineralocorticoid receptor antagonists in heart failure

3' education - Nov. 10, 2015 - AHA 2015, Orlando, FL, USA - Prof Bertram Pitt

Video navigation menu

Mineralocorticoid receptor antagonists (MRAs) in heart failure 0:00
Development of new non-steroidal MRAs 1:09
ODD-trial: comparing finerenone with spironolactone in HF and renal disease 1:41
ODD-HF trial: comparing finerenone with eplenerone 2:17
Ongoing and upcoming studies evaluating finerenone in patients with diabetic nephropathy 2:58

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.